Additional Data Support Efficacy of Molnupiravir for Mild to Moderate COVID-19
The phase 3 MOVe-OUT trial included all 1433 at risk adults with mild to moderate COVID-19 and symptom onset within 5 days of randomization.
COVID19
Moderna to Test COVID-19 Booster Candidates Against Omicron Variant
A new booster candidate specific for Omicron is also being planned.
Pandemic Had Greater Effect on Work-Life Balance for Female Physicians
A sizable gender gap evident for risk of depression and anxiety
Risk for Stillbirth Elevated for Deliveries With COVID-19
Adjusted relative risk for stillbirth higher in deliveries with COVID-19 in pre-delta and delta periods, with stronger link during delta period
Thirty Percent of Hospital-Based Health Care Personnel Unvaccinated
COVID-19 vaccination coverage increased from 36.1 to 60.2 percent from January to April 2021, then slowed, reaching 70.0 percent as of Sept. 15
Longer-Term Data: Pfizer-BioNTech COVID-19 Vaccine Highly Effective in Adolescents
Findings from data collected between November 2020 and September 2021 showed that among 2228 participants, the vaccine was 100% effective.
COVID-19 Booster Shots Authorized for All Individuals 18 and Up
Both Companies provided data demonstrating waning neutralizing antibody titers approximately 6 months after completion of the primary series.
MPR Weekly Dose Podcast Episode 100
This week Pfizer seeks Emergency Use Authorization for their COVID-19 oral antiviral; A meta-analysis found commonly prescribed drugs were linked to orthostatic hypotension; A novel treatment is approved for polycythemia vera; A new program has been cleared to allow individuals to carry out remote endoscopy procedures; And the largest to date psilocybin trial shows promise in treatment-resistant depression.
Long-Acting Antibody Combo Reduced Risk of Symptomatic COVID-19 in Phase 3 Trials
AZD7442 is a combination of 2 long-acting monoclonal antibodies, tixagevimab and cilgavimab, derived from B-cells donated by convalescent patients who were infected with the SARS-CoV-2 virus.
CDC: More Than 100,000 Americans Died From Drug Overdoses in 1 Year
Figure is almost 30 percent higher than the previous year, when 78,000 overdose deaths were reported
